California Archive » February, 2008

California - February, 2008

124 articles

• Calif. Power Deregulation Plans Spark Criticism
• Fed. Circuit Reverses DRAM Patent Suit Dismissal
• Calif. Patent Rule Changes May Be Traps For Unwary
• Federal Circuit Issues Mixed Ruling In Dako Case
• DRAM Antitrust Plaintiffs File 3rd Amended Complaint
• Digital TV Cos. Sue In Germany Over MPEG-2 Patents
• Judge Denies Four Milberg Motions To Dismiss
• BlackBerry Maker Prevails In U.K. Patent Clash
• Utility Asks FERC To Consider Power Corridor
• Yahoo Faces Shareholder Suits After Microsoft Bid
• Court Accepts $4M Settlement In Security Officer Suit
• Legal And Regulatory Calendar
• DLA Piper Snags Heller Ehrman Life Sciences Chair
• Calif. Can't Regulate Ship Emissions: 9th Circuit
• $20M Securities Scam Results In 18-Year Jail Term
• Judge To Reconsider 2nd Claim In Stent Dispute
• Foley & Lardner May Add Defenses Over Patent Filing
• Agencies Balk At Pacific Lumber Disclosure Statement
• Alaskan Town Sues ExxonMobil, Others Over GHGs
• Chevron Loses Bid To Sanction Nigerian Riot Plaintiff
• Bio-Imaging Rivals Lay Patent Claims To Rest
• Tessera's ITC Case Stayed For Re-Examination
• Pacific Lumber Demands BNY Return $1M
• Execs Promise Safer Food To Skeptical Lawmakers
• Documents Reveal EPA Staff Support For Nixed Waiver
• Seoul Semi Seeks To Reverse LED Patent Verdict
• New Trial Order Upheld In BNY Ponzi Scheme Case
• Hedge Fund Manager Gets 5 Years For Fraud
• Suit Over Bad Whirlpool Fridges To Move Forward
• Bluetooth Parties Seek Stay Amid Settlement Talks
• Energy Cos. Win A Round In Price-Fixing MDL
• Nigerian State Drops $23B Tobacco Suit
• Judge Denies Class Status To Wells Fargo Workers
• San Francisco Bay Area Suburb May Go Bust: Report
• Arbitration Trumps State Laws: Supreme Court
• High Court Won't Block Employer-Funded Health Care
• N. District Of Calif. Streamlines Patent Trial Rules
• KLA-Tencor Execs Spared Grilling By Ex-CEO
• For The 2nd Time, Judge OKs $35M Veritas Deal
• L.A. City Attorney Sues Health Net Over Recission
• Federal Circuit Sends Back Slot Patent Case
• Winston & Strawn Hires 3 To Enhance IP Practice
• Tyco Unit Wins Jury Verdict In Patent Dispute
• Buchanan Ingersoll Snaps Up Securities Veteran
• Court Consolidates CRT Price-Fixing Class Actions
• ST's Bid For Injunction V. Tessera Fails, Again
• Subprime Litigation Likely To Surpass S&L Suits: Study
• Judge Refuses To Toss Energy Price-Fixing Case
• Senator Weighs In On Pacific Lumber Bankruptcy
• French Prosecutor To Appeal Queen Mary 2 Verdict
• Once On Cutting Edge, Sharper Image Files For Ch. 11
• No Shares, No Derivative Suit: Calif. Court
• Kansas Bill To Build Coal-Fired Plants Advances
• Reed Smith Adds Fifth New Partner In Two Weeks
• Plaintiff Denied Class Status In Wyeth Hormone Suit
• Wyeth Claims Victory In Thimerosal-Autism Case
• Broadcom Wins Judgment In Video Patent Case
• King & Spalding Expands In California
• Funds Accuse Countrywide Of Shielding Executives
• States, Investors Pledge $10B To Energy Efficiency
• SLUSA As A Defense In Excessive Fees Litigation
• American Funds Settles "Shelf Space" Suit: Report
• Organic Grower Sues Suppliers Over Salmonella
• Judge Lets HHS Proceed With Bidding On Lab Tests
• State, Federal Regulators To Discuss Smart Grid
• Oracle, SAP Trade Secrets Feud Sent To Mediation
• SRAM Complaints Partially Tossed
• Openwave Backdating Claims Fall Short, Again
• Goldman Sachs, UC Strike $11M Deal In Enron Suit
• The FTDRA In Its First Year
• Justices Asked To Block Employer-Funded Health Care
• Judge Certifies Class Of Managers In FedEx OT Suit
• Class Certified In Wal-Mart Wage-And-Hour Suit
• Abbott Must Face Overtime Claims In California
• Jackson Lewis Countines Expansion In Southwest
• Lilly Wins Bid To Shift Zyprexa Whistleblower Suit
• Judge Says No To Injunction Against Tessera
• Edwards' Valve Patent Dispute Crosses Atlantic
• Calif. Employers Need Not Hire Medical Marijuana Users
• U.S. Must Pay For WWII Plane-Gas Cleanup: Judge
• JP Morgan Faces Class Action By N.Y. Loan Officers
• Senate Backs Bush On Eavesdropping Program
• Grocers Must Face Dyed Salmon Claims
• Hedge Fund Sues Transmeta, An Acquisition Target
• Court Assesses $13M Damages In Fatal QM2 Mishap
• Lerach Sentenced To Two Years Behind Bars
• Pacific Lumber Resolves $1B In Qui Tam Claims
• Federal Circuit Reverses Patent Ruling Against IXYS
• University Coach's $19M Gender Bias Award Slashed
• Injunction Affirmed In Alliant Trade Secrets Case
• Lerach Sentence Not Good News For Weiss, Firm
• Ch. 11 Plan Should Trump Price-Fixing Suit: Northwest
• KB Home, Countrywide Faked Home Appraisals: Suit
• Another Suit Over Schering's Clarinex Added To MDL
• Lawmakers Subpoena EPA's Documents On Emissions
• Morgan Stanley's $16M Deal In Bias Suit Gets Nod
• Judge Nixes Nichia's Bid For Injunction On LEDs
• UPS, Truckers Bury Hatchet Over Wage Policies
• Jackson Lewis Expands West To Las Vegas, Detroit
• Welders Drop Medical Monitoring Claims From MDL
• An Assignment's Effect On Hypothetical Negotiation
• SEC Settles With Lawyer Accused In Pump-And-Dump
• 'Rocket Dockets' Gaining On Popular E. Texas Court
• Amgen Shareholder Anemia Drug Suit To Proceed
• Korean Businessman To Pay $50M For Stock Scandal
• Ex-KPMG Director Settles In Peregrine Case
• Fry's Resists Paying Fees In Intel Antitrust Case
• Trouble For Health Care Still Brews After Bly-McGee
• SRAM Cos. Ask Judge To Consider DRAM Ruling
• Ford Must Fork Over $6.5M To Rollover Victim
• Asarco Asks To Sell Assets To Aid Reorganization
• Study Warns Of Potential Hazard In Baby Products
• IP Attorney Disbarred For Insider Trading
• Judge Allows Supplemental Briefs In Enron Suit
• Lack Of Standing Halts Quantum's Infringement Suit
• A Matter Of FACTA: Legal And Legislative Crossroads
• Medical Device Co. Sued Over Valve Patent
• Ciena To Pay $7.7M And Drop Out Of Patent Spat
• Reed Smith Adds Three New Partners To L.A. Offices
• Platforms Wireless Can Rebrief SEC Claims: Judge
• Bankruptcy Puts Excel-Invidos Patent Spat On Hold
• Roche Loses Round In HIV Test Patent Case
• Court Orders New Trial In $28B Philip Morris Case
• Judge Nixes Paxil Warning-Label Suit Against Glaxo